logo-loader

T1D Exchange building 'largest, most integrated' type 1 diabetes data platform in the US

Published: 15:13 11 Feb 2019 EST

T1D Exchange CEO Dr. Dara Schuster sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.

T1D Exchange is a nonprofit research organization dedicated to accelerating therapies and improving care for people living with type 1 diabetes.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

2 hours, 42 minutes ago